(Q34655404)

3 August 2017

title

The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. (English)

1 reference

3 August 2017

1 reference

Samantha L Butler

1

1 reference

3 August 2017

Huijia Dong

2

1 reference

3 August 2017

Diana Cardona

3

1 reference

3 August 2017

Minghong Jia

4

1 reference

3 August 2017

Ran Zheng

5

1 reference

3 August 2017

Haizhen Zhu

6

1 reference

3 August 2017

James M Crawford

7

1 reference

3 August 2017

Chen Liu

8

1 reference

3 August 2017

publication date

19 November 2007

1 reference

3 August 2017

published in

Laboratory Investigation

1 reference

3 August 2017

volume

88

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

78-88

1 reference

Pathology of Food-Borne Infectious Diseases of the Gastrointestinal Tract: An Update

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Hepatocyte antigen as a marker of intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Dietary calorie restriction in mice induces carbamyl phosphate synthetase I gene transcription tissue specifically

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Urea synthesis in enterocytes of developing pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

The presence of carbamyl phosphate synthetase in intestinal mucosa

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Hepatocyte paraffin 1 immunoexpression in esophageal brush samples

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

AMINO ACID METABOLISM

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Lethal neonatal deficiency of carbamyl phosphate synthetase.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Compartmentation and kinetics of urea cycle enzymes in porcine enterocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700699

7 January 2021

10.1038/LABINVEST.3700699

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1028386908

0 references

1 reference